Viewing StudyNCT05430347



Ignite Creation Date: 2024-05-06 @ 5:48 PM
Last Modification Date: 2024-10-26 @ 2:35 PM
Study NCT ID: NCT05430347
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-02-21
First Post: 2022-06-12

Brief Title: Clinical Study of Pyrotinib in Neoadjuvant Therapy of HR-positive and HER2-positive Breast Cancer
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Organization: The First Affiliated Hospital with Nanjing Medical University

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-04-15
Start Date Type: ESTIMATED
Primary Completion Date: 2025-06-15
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-09-30
Completion Date Type: ESTIMATED
First Submit Date: 2022-06-12
First Submit QC Date: June 19 2022
Study First Post Date: 2022-06-24
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-02-19
Last Update Post Date: 2023-02-21
Last Update Post Date Type: ACTUAL